0.4215 USD
-0.15 (-26.22%)
0.3089 USD
-0.11 (-26.71%)
ChartMill assigns a Buy % Consensus number of 46% to CMAX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.25. This target is 10160.5% above the current price.
CMAX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about CMAX.
In the previous month the buy percentage consensus was at a similar level.
CMAX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-01 | UBS | Maintains | Neutral -> Neutral |
| 2023-11-17 | UBS | Downgrade | Buy -> Neutral |
| 2023-11-10 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-01-06 | UBS | Maintains | Buy |
| 2022-09-07 | Truist Securities | Initiate | Hold |
| 2021-10-20 | Jefferies | Initiate | Buy |
| 2021-09-13 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-09-10 | Cowen & Co. | Initiate | Outperform |
| 2021-07-01 | Piper Sandler | Initiate | Neutral |
CAREMAX INC / CMAX FAQ
What is the average price target for CAREMAX INC (CMAX) stock?
7 analysts have analysed CMAX and the average price target is 43.25 USD. This implies a price increase of 10160.5% is expected in the next year compared to the current price of 0.4215.
What is the consensus rating for CAREMAX INC (CMAX) stock?
The consensus rating for CAREMAX INC (CMAX) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.